2011 Summit: Government

Posted: December 14, 2011 at 8:59 am



Robert Klein, former chair of the California Institute of Regenerative Medicine (CIRM), presented this year's advocacy keynote, addressing the looming black cloud over funding for stem cell research in the US. Klein explained that in a financial downturn, creating long term, big picture investments for donors is absolutely necessary to bring to new treatment modalities to market. He called for scientists to become advocates and stressed that broad public understanding of stem cell science is also critical to the future of regenerative medicine.

More:
2011 Summit: Government

Related Post

Comments are closed.

Archives